ATE82124T1 - Anwendung von n-(2-(diaethylamino)aethyl>-2-methoxy-4((1-h-4,5ihydro-2-imidazolyl)amino>-5- chlorobenzamid als anxiolytisches und antipsychotisches mittel. - Google Patents

Anwendung von n-(2-(diaethylamino)aethyl>-2-methoxy-4((1-h-4,5ihydro-2-imidazolyl)amino>-5- chlorobenzamid als anxiolytisches und antipsychotisches mittel.

Info

Publication number
ATE82124T1
ATE82124T1 AT87401364T AT87401364T ATE82124T1 AT E82124 T1 ATE82124 T1 AT E82124T1 AT 87401364 T AT87401364 T AT 87401364T AT 87401364 T AT87401364 T AT 87401364T AT E82124 T1 ATE82124 T1 AT E82124T1
Authority
AT
Austria
Prior art keywords
sychotic
diaethylamino
5ihydro
aethyl
chlorobenzamide
Prior art date
Application number
AT87401364T
Other languages
English (en)
Inventor
Jacques Acher
Jean-Claude Monier
Jean-Paul Schmitt
Brenda Costall
Robert Naylor
Original Assignee
Delagrange Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delagrange Lab filed Critical Delagrange Lab
Application granted granted Critical
Publication of ATE82124T1 publication Critical patent/ATE82124T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
AT87401364T 1987-06-17 1987-06-17 Anwendung von n-(2-(diaethylamino)aethyl>-2-methoxy-4((1-h-4,5ihydro-2-imidazolyl)amino>-5- chlorobenzamid als anxiolytisches und antipsychotisches mittel. ATE82124T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87401364A EP0295350B1 (de) 1987-06-17 1987-06-17 Anwendung von N-[2-(diäthylamino)äthyl]-2-methoxy-4[(1-H-4,5-dihydro-2-imidazolyl)amino]-5-chlorobenzamid als anxiolytisches und antipsychotisches Mittel

Publications (1)

Publication Number Publication Date
ATE82124T1 true ATE82124T1 (de) 1992-11-15

Family

ID=8198221

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87401364T ATE82124T1 (de) 1987-06-17 1987-06-17 Anwendung von n-(2-(diaethylamino)aethyl>-2-methoxy-4((1-h-4,5ihydro-2-imidazolyl)amino>-5- chlorobenzamid als anxiolytisches und antipsychotisches mittel.

Country Status (5)

Country Link
US (2) US5116859A (de)
EP (1) EP0295350B1 (de)
JP (1) JPS6485914A (de)
AT (1) ATE82124T1 (de)
DE (1) DE3782651T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
FR2640507A1 (fr) * 1988-12-20 1990-06-22 Delagrange Laboratoires Application de benzamides substitues comme anxiolytiques et anti-psychotiques
FR2645742A1 (fr) * 1989-04-12 1990-10-19 Delagrange Laboratoires Application de derives de 2-methoxy 4-(4,5-dihydro 2-imidazolyl (ou 2-oxazolyl) amino) 5-chloro benzamide dans le traitement des troubles de la fonction cognitive
US20040251175A1 (en) * 1998-10-30 2004-12-16 Adams Thomas C. Apparatuses and methods for making glued screen assemblies
US20100144885A1 (en) * 2006-09-29 2010-06-10 The Board Of Trustees Of The University Of Illinois Histone acetyl transferase activators and histone deacetylase inhibitors in the treatment of alcoholism

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
US4210660A (en) * 1978-12-20 1980-07-01 Yamanouchi Pharmaceutical Co., Ltd. Benzamide derivatives
FR2592042B1 (fr) * 1985-12-19 1988-03-25 Ile De France Nouveaux ortho-anisamides, leur procede d'obtention, et leurs applications therapeutiques
GB8718345D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides
US4887780A (en) * 1988-12-30 1989-12-19 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Orbiter escape pole

Also Published As

Publication number Publication date
EP0295350A3 (en) 1990-07-04
EP0295350B1 (de) 1992-11-11
US5141949A (en) 1992-08-25
DE3782651T2 (de) 1993-03-25
EP0295350A2 (de) 1988-12-21
US5116859A (en) 1992-05-26
DE3782651D1 (de) 1992-12-17
JPS6485914A (en) 1989-03-30

Similar Documents

Publication Publication Date Title
NO990405L (no) Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler
DE59006506D1 (de) Transdermale Applikation von 2-Amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol.
DE69316223T2 (de) Sulfonylalkanoylaminohydroxyethylaminosulfonamide verwendbar als retrovirale protease-inhibitoren
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
DE69232665T2 (de) Neue 4-arylpiperazine und 4-arylpiperidine
ATE243694T1 (de) 4-mercaptoacetylamino-(2)benzazepinon(3)- derivate, und verwendung als enkephalinase- inhibitoren
MX9102138A (es) Inhibidores de proteasa retroviral
FI915093A0 (fi) Sackarinderivat anvaendbara som inhibitorer foer proteolytiskt enzym och deras framstaellning.
BR0009767A (pt) Agentes inibitórios e quimiotáticos derivados de osteopontina e seus usos
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
ATE204021T1 (de) Klonierung, expression und charakterisierung einer neuen form der phosphatidylinositol-3- kinase
ATE82124T1 (de) Anwendung von n-(2-(diaethylamino)aethyl>-2-methoxy-4((1-h-4,5ihydro-2-imidazolyl)amino>-5- chlorobenzamid als anxiolytisches und antipsychotisches mittel.
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
ATE57526T1 (de) P-acylaminobenzamide.
PT950056E (pt) N-(piridinilamino) isoindolinas e compostos relacionados
DK0535104T3 (da) Heterocyliske forbindelser deres fremstilling og anvendelse
EA200200321A1 (ru) Апоптин-ассоциированный белок
SE8304111D0 (sv) Amino derivatives of benzylidene-pyrrolo(2,1-b)-quinazolines and benzylidene-pyrido(2,1-b)quinazolines
ATE72112T1 (de) Verwendung von 1-benzyl-amino-alkylpyrrolidinonen als antidepressiva.
ES2016857B3 (es) Derivados de 4 - feniltiazol.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties